0001567619-19-023140.txt : 20191216
0001567619-19-023140.hdr.sgml : 20191216
20191216161232
ACCESSION NUMBER: 0001567619-19-023140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191212
FILED AS OF DATE: 20191216
DATE AS OF CHANGE: 20191216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones William Benton
CENTRAL INDEX KEY: 0001664506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 191287246
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD, SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc1.xml
FORM 4
X0306
4
2019-12-12
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001664506
Jones William Benton
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
0
1
0
0
See Remarks
Stock Option (Right to Buy)
3.54
2019-12-12
4
A
0
160000
0.00
A
2029-12-12
Common Stock
160000
160000
D
The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
SVP, Pharmaceutical Development
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
2019-12-16